Paraic A Kenny

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Venues

F1000Research

Antibody therapeutics

Developmental dynamics : an official publication of the American Association of Anatomists

JCO precision oncology

Gundersen Lutheran Medical Foundation

Institute of Cancer Research (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Gundersen Lutheran Medical Foundation Oct 05 2015

United States

Director :: Kabara Cancer Research Institute

Albert Einstein College of Medicine, Yeshiva University Jul 01 2014 - Sep 30 2015

United States

Associate Professor :: Developmental and Molecular Biology

Albert Einstein College of Medicine, Yeshiva University May 01 2008 - Jun 30 2014

United States

Assistant Professor :: Developmental and Molecular Biology

Lawrence Berkeley National Laboratory Jul 01 2002 - Jun 30 2008

United States

Postdoctoral Fellow :: Life Sciences Division

Education History

Institute of Cancer Research Oct 10 1998 - Jun 30 2002

United Kingdom

PHD :: Gene Function and Regulation

University College Cork Oct 01 1994 - Jun 30 1998

Ireland

BSC :: Biochemistry

Publications

Sean R O'Neil, Garrett A Weber, Dustin A Deming, Mark E Burkard, Paraic A Kenny, Craig S Richmond, Benjamin M Parsons
Exceptional Response to Crizotinib With Subsequent Response to Cabozantinib in Metastatic, ROS1-GOPC Fusion-Mutated Breast Cancer. JCO precision oncology 7 (2023)
Kristopher A Lofgren, Paraic A Kenny
Grb7 knockout mice develop normally but litters born to knockout females fail to thrive. Developmental dynamics : an official publication of the American Association of Anatomists 253 (7) (2023)
Kristopher A Lofgren, Paraic A Kenny
Grb7 knockout mice develop normally but litters born to knockout females fail to thrive. Developmental dynamics : an official publication of the American Association of Anatomists (2023)
Kristopher A Lofgren, Nicolette C Reker, Sreeja Sreekumar, Paraic A Kenny
Pan-cancer distribution of cleaved cell-surface amphiregulin, the target of the GMF-1A3 antibody drug conjugate. Antibody therapeutics 5 (3) (2022)
Kristopher A Lofgren, Sreeja Sreekumar, E Charles Jenkins, Kyle J Ernzen, Paraic A Kenny
Anti-tumor efficacy of an MMAE-conjugated antibody targeting cell surface TACE/ADAM17-cleaved Amphiregulin in breast cancer. Antibody therapeutics 4 (4) (2021)
Paraic A Kenny
InferAMP, a python web app for copy number inference from discrete gene-level amplification signals noted in clinical tumor profiling reports. F1000Research (2019)
Paraic A Kenny
InferAMP, a python web app for copy number inference from discrete gene-level amplification signals noted in clinical tumor profiling reports. F1000Research 8 (2019)
Paraic A Kenny
InferCNV, a python web app for copy number inference from discrete gene-level amplification signals noted in clinical tumor profiling reports. F1000Research (2019)
David R Meier, Megan A Girtman, Kristopher A Lofgren, Paraic A Kenny
Amphiregulin deletion strongly attenuates the development of estrogen receptor-positive tumors in p53 mutant mice. Breast cancer research and treatment 179 (3) (2019)
Stephanie L Fricke, Susan N Payne, Peter F Favreau, Jeremy D Kratz, Cheri A Pasch, Tyler M Foley, Alexander E Yueh, Dana R Van De Hey, Mitchell G Depke, Demetra P Korkos, Gioia Chengcheng Sha, Rebecca A DeStefanis, Linda Clipson, Mark E Burkard, Kayla K Lemmon, Benjamin M Parsons, Paraic A Kenny, Kristina A Matkowskyj, Michael A Newton, Melissa C Skala, Dustin A Deming
MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers. Molecular cancer therapeutics 18 (2) (2018)
Jerry J Miller, Kristopher A Lofgren, Sarah R Hughes, Steven E Cash, Paraic A Kenny
Genomic analysis of melanoma evolution following a 30-year disease-free interval. Journal of cutaneous pathology 44 (9) (2017)

Paraic A Kenny.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Paraic A Kenny